HUP9802974A1 - Dna-vaccine for infections bursal disease - Google Patents

Dna-vaccine for infections bursal disease

Info

Publication number
HUP9802974A1
HUP9802974A1 HU9802974A HUP9802974A HUP9802974A1 HU P9802974 A1 HUP9802974 A1 HU P9802974A1 HU 9802974 A HU9802974 A HU 9802974A HU P9802974 A HUP9802974 A HU P9802974A HU P9802974 A1 HUP9802974 A1 HU P9802974A1
Authority
HU
Hungary
Prior art keywords
dna
vaccine
invention further
recombinant plasmid
bursal disease
Prior art date
Application number
HU9802974A
Other languages
Hungarian (hu)
Inventor
István Fodor
Shyam K. Dube
Ernő Horváth
Vikhram N. Vakharia
Original Assignee
Mezőgazdasági Biotechnológiai Kutatóközpont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mezőgazdasági Biotechnológiai Kutatóközpont filed Critical Mezőgazdasági Biotechnológiai Kutatóközpont
Priority to HU9802974A priority Critical patent/HUP9802974A1/en
Publication of HU9802974D0 publication Critical patent/HU9802974D0/en
Priority to PCT/IB1999/002022 priority patent/WO2000037649A2/en
Priority to AU16742/00A priority patent/AU1674200A/en
Publication of HUP9802974A1 publication Critical patent/HUP9802974A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A találmány csirkék fertőző betegségei, elsősőrban fertőzőbűrsitis (gűmbőrői betegség) elleni DNS-vakcinákra vőnatkőzik. A DNS-vakcina hatóanyaga egy rekőmbináns plamidvektőr, amely IBDV VP-VP4-VP3antigéneket kódőló DNS-szekvenciákat tartalmaz állati sejtekbenhatékőny génexpressziót biztősító eűkarióta szabályőzó elemekkelműködőképesen összekapcsőlva. A találmány tárgyát képeziktővábbá az új rekőmbináns plazmid vektőrők és ezek alkalmazása csirkékimműnizálására, és DNS-vakcinák előállítására. A találmány tárgyatővábbá egy új eljárás plazmid DNS tisztítására. ŕ The invention is based on DNA vaccines against infectious diseases of chickens, primarily infectious bursitis (fungal skin disease). The active ingredient of the DNA vaccine is a recombinant plasmid vector, which contains DNA sequences encoding IBDV VP-VP4-VP3 antigens, functionally linked with eukaryotic regulatory elements that ensure efficient gene expression in animal cells. The invention further relates to new recombinant plasmid vectors and their use for chicken immunization and the production of DNA vaccines. The invention further discusses a new method for the purification of plasmid DNA. ŕ

HU9802974A 1998-12-19 1998-12-19 Dna-vaccine for infections bursal disease HUP9802974A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
HU9802974A HUP9802974A1 (en) 1998-12-19 1998-12-19 Dna-vaccine for infections bursal disease
PCT/IB1999/002022 WO2000037649A2 (en) 1998-12-19 1999-12-17 Dna vaccine against infectious bursal disease virus
AU16742/00A AU1674200A (en) 1998-12-19 1999-12-17 Dna vaccine against infectious bursal disease virus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9802974A HUP9802974A1 (en) 1998-12-19 1998-12-19 Dna-vaccine for infections bursal disease

Publications (2)

Publication Number Publication Date
HU9802974D0 HU9802974D0 (en) 1999-02-01
HUP9802974A1 true HUP9802974A1 (en) 2000-09-28

Family

ID=89997575

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9802974A HUP9802974A1 (en) 1998-12-19 1998-12-19 Dna-vaccine for infections bursal disease

Country Status (3)

Country Link
AU (1) AU1674200A (en)
HU (1) HUP9802974A1 (en)
WO (1) WO2000037649A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2310062B1 (en) 2005-07-15 2009-11-13 Bionostra, S.L. PSEUDOVIRAL PARTICLES CHEMICAL EMPTY DERIVED FROM VIRUS CAUSING INFECTIOUS BURSITIS DISEASE (IBDV), PROCEDURE OF OBTAINING AND APPLICATIONS.
KR100825503B1 (en) 2007-01-26 2008-04-25 강원대학교산학협력단 Vaccine composition for preventing infectious bursal disease
KR101104911B1 (en) 2010-04-19 2012-01-12 주식회사 바이오포아 Avirulent infectious bursal disease virus and use thereof as a vaccine
CN113088539A (en) * 2021-02-26 2021-07-09 华南农业大学 Recombinant adenovirus expressing IBDV VP2 protein, preparation and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08322559A (en) * 1995-06-02 1996-12-10 Chemo Sero Therapeut Res Inst Recombinant herpes virus using gb-gene promoter
US5871744A (en) * 1996-09-05 1999-02-16 University Of Maryland-Biotechnology Inst. Method for generating birnavirus from synthetic RNA transcripts

Also Published As

Publication number Publication date
HU9802974D0 (en) 1999-02-01
WO2000037649A3 (en) 2000-08-17
AU1674200A (en) 2000-07-12
WO2000037649A2 (en) 2000-06-29

Similar Documents

Publication Publication Date Title
DE69730839T2 (en) CHICKEN POLYNUCLEOTIDE VACCINE FORMULATION
Fodor et al. Induction of protective immunity in chickens immunised with plasmid DNA encoding infectious bursal disease virus antigens
ATE85622T1 (en) CHIMERIC GLYCOPROTEINS CONTAINING IMMUNOGENIC SEGMENTS OF HUMAN RESPIRATORY SYNCYTIAL VIRUS.
CZ298915B6 (en) Vaccine formula containing parainfluenza virus type 3 gene for vaccination of cattle against respiratory disease
CZ15999A3 (en) Formulation of polynucleotide vaccine of cats
DE69632235D1 (en) Newcastle disease viral vaccines combined
DE69939747D1 (en) METHOD OF DNA VACCINATION
AU741055B2 (en) A method for generating birnavirus from synthetic RNA transcripts
EA200100302A1 (en) METHODS AND COMPOSITIONS FOR PROTECTIVE AND THERAPEUTIC GENETIC IMMUNIZATION
UA84667C2 (en) Vaccine directed against infection induced by herpes virus of marek's disease
HUP9802974A1 (en) Dna-vaccine for infections bursal disease
DE69635472D1 (en) Vaccine against poultry coccidosis
Satya et al. A pattern matching algorithm for codon optimization and CpG motif-engineering in DNA expression vectors
EP1490105B1 (en) Multiple and multivalent dna vaccines in ovo
HUP0102306A1 (en) A polypeptide comprising the amino acid of an n-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
AP2000001892A0 (en) Self-replicating vector for DNA immunization against HIV.
Tomley Recombinant vaccines for poultry
DE69939212D1 (en) POLYPEPTIDE WITH ACTIVITY AGAINST THE HUMAN IMMUNEFICIENCY VIRUS, ENCODING GENES AND PROCESS FOR PREPARING THE POLYPEPTIDE
KR930701588A (en) Recombinant oral virus vaccine
PL341724A1 (en) Mutated newcastle disease virus (ndv) and method of obtaining same, live or inactivated vaccine containing same and method of obtaining such vaccine
EP1082011A4 (en) Avian polyomavirus vaccines in psittacine birds
AR007611A1 (en) CHICKEN CELL LINE INFECTED WITH DURABLE MAREK DISEASE VIRUS, METHOD FOR PRODUCING THE CELL LINE, BIRD VACCINE AND HERPESVIRUS LINE OF MAREK DISEASE
AR012944A1 (en) PREPARATION OF MAREK'S DISEASE VIRUSES USING CONTINUOUS MAMMALIAN CELL LINES
Moss et al. Vaccinia virus vectors: Potential use as live recombinant virus vaccines.
Morgan et al. Recombinant vaccine against Marek's disease